Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
97.20    -0.70 (-0.72%)
Bid:
97.10
Ask:
98.20
Spread: 1.10 (1.133%)
Market Cap: £591.16m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Syncona News

Syncona net assets values down; announces new portfolio firm Slingshot
14 Nov 2024

Syncona net assets values down; announces new portfolio firm Slingshot

(Alliance News) - Syncona Ltd on Thursday said it launched a new portfolio company as it reported a fall in net asset value, citing a weaker US dollar...

Syncona launches Slingshot platform with £12.5m investment
14 Nov 2024

Syncona launches Slingshot platform with £12.5m investment

(Sharecast News) - Syncona announced the launch of Slingshot Therapeutics, a new portfolio company and accelerator dedicated to developing early-stage...

Syncona's Autolus wins FDA approval for aggressive leukaemia therapy
11 Nov 2024

Syncona's Autolus wins FDA approval for aggressive leukaemia therapy

(Alliance News) - Syncona Ltd announced on Monday that the US Food & Drug Administration has granted marketing approval to one of its portfolio compan...

Syncona's Autolus gets FDA approval for leukaemia treatment
11 Nov 2024

Syncona's Autolus gets FDA approval for leukaemia treatment

(Sharecast News) - Life science investor Syncona announced on Monday that its portfolio company Autolus Therapeutics has received US Food and Drug Adm...

Syncona celebrates investee's positive trial data on Gaucher disease
23 Oct 2024

Syncona celebrates investee's positive trial data on Gaucher disease

(Alliance News) - Syncona Ltd on Wednesday noted positive trial results for a portfolio company's gene therapy aimed at treating people with Gaucher's...

TRADING UPDATES: Strix lauds "milestone"; Quartix to meet expectations
15 Oct 2024

TRADING UPDATES: Strix lauds "milestone"; Quartix to meet expectations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Syncona makes further investment in Purespring Therapeutics
9 Oct 2024

Syncona makes further investment in Purespring Therapeutics

(Alliance News) - Syncona Ltd on Wednesday announced it has committed GBP19.9 million in a series B financing of Purespring Therapeutics, which will b...